Borrelia Burgdorferi Bacterial Extract

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

710.0%

Death Rate

Active Ingredients

Borrelia Burgdorferi Bacterial Extract

Administration Routes

SubcutaneousUnknownParenteral

Species Affected

Dog 14

Most Affected Breeds

Poodle - Miniature 2

Retriever - Labrador 2

Beagle 2

Doberman Pinscher 1

Dachshund (unspecified) 1

Shepherd Dog - Australian 1

Siberian Husky 1

Chow Chow 1

Shepherd Dog - German 1

Spaniel (unspecified) 1

Most Reported Reactions

Lack of efficacy (bacteria) - Borrelia 6

Epistaxis 2

Injection site pain 2

Vocalisation 2

Limping 2

Lethargy (see also Central nervous system depression in Neurological) 2

Immune mediated thrombocytopenia 1

Joint effusion 1

Bloody diarrhoea 1

Unable to stand 1

Death by euthanasia 1

Lethargy (see also Central nervous system depression in 'Neurological') 1

Outcome Breakdown

Outcome Unknown

6 (42.9%)

Recovered/Normal

5 (35.7%)

Ongoing

2 (14.3%)

Euthanized

1 (7.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.